CannBioRx Life Sciences (ATNFW) has had the highest return since August 1, 2025 by a US stock, returning 3,259.4%.
| ASSET | % RETURN |
|---|---|
CannBioRx Life Sciences (ATNFW) | 3,259.38% |
Azitra (AZTR) | 416.72% |
Advent Technologies (ADNWW) | 293.62% |
Cognition Therapeutics (CGTX) | 263.64% |
Ainos (AIMDW) | 253.92% |
Bolt Projects (BSLK) | 249.6% |
BT Brands Inc Warrant (BTBDW) | 234.62% |
Zepp Health (ZEPP) | 208.43% |
BioXcel Therapeutics (BTAI) | 203.61% |
Real Messenger Corporation Ordinary Shares (RMSG) | 196.02% |
Tharimmune (THAR) | 187.2% |
Nukkleus (NUKKW) | 186.05% |
Equillium (EQ) | 185% |
Atlantic International Corp Common Stock (ATLN) | 162.5% |
Jyong Biotech Ltd Ordinary Shares (MENS) | 150% |
Trinity Biotech (TRIB) | 148.57% |
Real Messenger Corporation Warrants (RMSGW) | 145.91% |
Telos (TLS) | 141.2% |
Advent Technologies (ADN) | 140.86% |
180 Life Sciences (ATNF) | 137.84% |
GCM Grosvenor (GCMGW) | 133.61% |
Chardan NexTech Acquisition 2 (DFLIW) | 129.06% |
Bolt Projects (BSLKW) | 117.5% |
flyExclusive, Inc WT (FLYX.WT) | 114.29% |
Thayer Ventures Acquisition (TVACW) | 113.14% |
